| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/15/2014 | CN103509006A Flumatinib mesylate crystal form, and preparation method and use thereof |
| 01/15/2014 | CN103509005A Quinazoline compound as well as preparation method and application thereof |
| 01/15/2014 | CN103509004A Dabigatran caffeic acid salt as well as preparation method and application thereof |
| 01/15/2014 | CN103509003A Preparation method of azelnidipine |
| 01/15/2014 | CN103509002A Purification decolorization method of fasudil hydrochloride |
| 01/15/2014 | CN103509001A Esomeprazole magnesium trihydrate and preparation method thereof |
| 01/15/2014 | CN103509000A Method for synthesizing medicament intermediate 1-(3-cyanomethylpyridyl-2)-4-methyl-2-phenylpiperazine |
| 01/15/2014 | CN103508961A Antitumor drug |
| 01/15/2014 | CN103508957A Hydroxyethyl pyrazole compound or aminoethyl pyrazole compound, preparation method and use thereof |
| 01/15/2014 | CN103508950A 4-hydroxy-2-quinolinone compounds containing imine structure, and preparation and application thereof |
| 01/15/2014 | CN103508930A Bis(aminodithioformate)-1,3-propane diester compound, and synthesis method, pharmaceutical composition and use thereof |
| 01/15/2014 | CN102438626B Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 01/15/2014 | CN102341385B Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/15/2014 | CN102203067B Hedgehog pathway modulators |
| 01/15/2014 | CN102070614B Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
| 01/15/2014 | CN101525330B Phosphopyridoxal intermediates, preparation method of same, application of same, and method for preparing phosphopyridoxal therefrom |
| 01/15/2014 | CN101500999B Hydroxyphenyl derivatives and biological applications thereof |
| 01/14/2014 | US8629285 Imidazole compounds that modulate HSP90 activity |
| 01/14/2014 | US8629157 Pyrrolidine compounds which modulate the CB2 receptor |
| 01/14/2014 | US8629156 Tryptophan hydroxylase inhibitors |
| 01/14/2014 | US8629148 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 01/14/2014 | US8629141 Spiro-oxindole MDM2 antagonists |
| 01/14/2014 | US8629137 CGRP antagonists |
| 01/14/2014 | US8628863 Indenopyrene compound and organic light-emitting device using the compound |
| 01/14/2014 | CA2760535C Vinyl indazolyl compounds |
| 01/14/2014 | CA2747055C Substituted benzimidazole derivatives as protein kinase inhibitors |
| 01/14/2014 | CA2652443C 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 1 |
| 01/14/2014 | CA2649650C Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/14/2014 | CA2610193C Methods and intermediates for the preparation of optionally radio-labeled imatinib |
| 01/14/2014 | CA2602234C Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/14/2014 | CA2490147C Liquid dosage forms of non-enterically coated proton pump inhibitors |
| 01/09/2014 | WO2014008458A2 N-substituted benzamides and methods of use thereof |
| 01/09/2014 | WO2014008214A1 Biaryl-containing compounds as inverse agonists of ror-gamma receptors |
| 01/09/2014 | WO2014008197A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | WO2014007395A1 Pyrazole or thiazole derivative, salt thereof, and pest control agent |
| 01/09/2014 | WO2014007228A1 Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
| 01/09/2014 | WO2014005601A1 A process for the preparation of solifenacin or a salt thereof |
| 01/09/2014 | WO2014005421A1 Benzodioxole derivative and preparation method and use thereof |
| 01/09/2014 | WO2013013815A8 Substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/09/2014 | WO2012162254A8 Inhibitors of lrrk2 kinase activity |
| 01/09/2014 | US20140012006 Benzimidazole compound crystal |
| 01/09/2014 | US20140012005 Process for preparing chiral amino acids |
| 01/09/2014 | US20140011999 Method for Producing Phenoxypyridine Derivative |
| 01/09/2014 | US20140011997 Neprilysin inhibitors |
| 01/09/2014 | US20140011996 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 01/09/2014 | US20140011845 Chemical compounds |
| 01/09/2014 | US20140011840 Compounds of Modulating TRPV3 Function |
| 01/09/2014 | US20140011836 Method of treating neuropathic pain |
| 01/09/2014 | US20140011823 Novel phenylpyridine derivative and drug containing same |
| 01/09/2014 | US20140011816 Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators |
| 01/09/2014 | US20140011810 Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith |
| 01/09/2014 | US20140011808 1,2-disubstituted heterocyclic compounds |
| 01/09/2014 | US20140011803 Phenyl amino pyrimidine compounds and uses thereof |
| 01/09/2014 | US20140011801 Heteroaryl quinazoline derivatives |
| 01/09/2014 | US20140011796 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 01/09/2014 | US20140011771 S1p3 receptor inhibitors for treating pain |
| 01/09/2014 | US20140010892 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 01/09/2014 | CA2878000A1 Benzodioxole derivative and preparation method and use thereof |
| 01/09/2014 | CA2877999A1 Heterocyclic modulators of lipid synthesis |
| 01/08/2014 | EP2682393A1 Inhibitors of HCV NS5A comprising a bicyclic core. |
| 01/08/2014 | EP2682392A2 Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same |
| 01/08/2014 | EP2681216A2 Substituted 6,5-fused bicyclic heteroaryl compounds |
| 01/08/2014 | EP2681207A2 Heterocyclic compounds for the inhibition of pask |
| 01/08/2014 | EP2681206A1 Mst1 kinase inhibitors and methods of their use |
| 01/08/2014 | EP2681200A1 Benzimidazole inhibitors of the sodium channel |
| 01/08/2014 | EP2681198A1 Novel small-molecules as therapeutics |
| 01/08/2014 | EP2681197A1 Tetrasubstituted cyclohexyl compounds as kinase inhibitors |
| 01/08/2014 | EP2681195A1 Novel kinase inhibitors |
| 01/08/2014 | EP2681194A1 3-amino-pyridines as gpbar1 agonists |
| 01/08/2014 | EP2680887A1 Dipyridinium derivatives |
| 01/08/2014 | EP2680886A1 Substituted quinoline compounds and methods of use |
| 01/08/2014 | EP2680849A2 6-alkyl-n-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 01/08/2014 | EP2680847A1 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof |
| 01/08/2014 | EP2680843A2 Derivatives of pyrazole-substituted amino-heteroaryl compounds |
| 01/08/2014 | EP2680694A1 Histone deacetylase inhibitors |
| 01/08/2014 | CN103502244A Compound for increasing kinase active and application thereof |
| 01/08/2014 | CN103502243A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/08/2014 | CN103502239A Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (SKY) |
| 01/08/2014 | CN103502238A Fungicide hydroximoyl-tetrazole derivatives |
| 01/08/2014 | CN103502237A FAAH inhibitors |
| 01/08/2014 | CN103502236A Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid |
| 01/08/2014 | CN103502221A N-(3-carbamoylphenyl)-1h-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests |
| 01/08/2014 | CN103502219A Novel small-molecules as therapeutics |
| 01/08/2014 | CN103502217A Diarylacetylene hydrazide containing tyrosine kinase inhibitors |
| 01/08/2014 | CN103501784A Carboxamide compounds and their use as calpain inhibitors v |
| 01/08/2014 | CN103501612A Compounds for inhibiting cell proliferation in EGFR-driven cancers |
| 01/08/2014 | CN103497177A Amino heterocyclic aromatic compound serving as c-Met inhibitor, and preparation method thereof |
| 01/08/2014 | CN103497176A Ternary system electric storage material and preparation and application thereof |
| 01/08/2014 | CN103497175A Method for preparing lenalidomide |
| 01/08/2014 | CN103497174A Preparation and refining method of pomalidomide |
| 01/08/2014 | CN103497173A Novel compound having heterocyclic ring |
| 01/08/2014 | CN103497148A Hydroxylamine compounds and methods of their use |
| 01/08/2014 | CN103497146A 2-(N-alkyl piperidinol-4-amino)-4-(substituent phenol) benzene ring derivative as well as preparation method and application thereof |
| 01/08/2014 | CN103497114A NMDA receptor antagonists for neuroprotection |
| 01/08/2014 | CN103495169A Methods and compositions for treatment and control of multiple myeloma |
| 01/08/2014 | CN103494817A Methods and compoistions used for treatment and control of multiple myeloma |
| 01/08/2014 | CN102558154B Lansoprazole crystalline compound, enteric capsule thereof and preparation method of Lansoprazole crystalline compound |
| 01/08/2014 | CN102532102B Preparation method for imazapyr |
| 01/08/2014 | CN102382102B Amide compound |
| 01/08/2014 | CN102015689B Inhibitors of JNK |